Technical false positives

Be sure to remove the extraembryonic membrane. Failure to do this may result in the lower colorimetric detection due to the reduced penetration of the probe. If technically difficult, the extraembryonic membrane should be at least partially torn. Additionally, be sure to puncture the vesicular structures such as brain, heart, and otic vesicles to prevent the false-positive staining caused by trapping of the probe. 

The decision about which error is more important is not a scientific question that can be resolved through technical analysis. It is a value choice. Of course, better scientific knowledge reduces the probability of making incorrect inferences abouf healfh effects. But even in situations of high certainty, the choice between false-positive and false-negative errors remains. And people invariably weigh the trade-offs differenfly. 

Standard of proof demanded (a) A formal calculation of power technically needs to take into account the standard of proof being required for a declaration of significance. The usual criterion is that the 95 per cent confidence interval excludes a zero effect (a =0.05). If an experiment was designed to achieve a higher standards of proof (e.g. a = 0.02), a 98 per cent Cl will have to be used and this will be wider than the standard 95 per cent CL The wider interval is then more likely to cross the zero line and so power will be lower. So, requiring a lower risk of a false positive (reducing alpha) will lead to less power. 

Since the initial paper by Fields and Song, there have been significant technical improvements in the method. DNA-binding domains and transcription activation domains have been optimized to reduce false positives and increase the transcription read-out. A variety of reporter plasmids have been engineered to detect a broad range of protein-protein interactions. Much more is understood about the nature of false positives and how to rout them out. Moreover, in response to the utility of this approach, several laboratories have begun to develop transcription-based assays that can be carried out in bacteria, or protein-protein interaction assays based on alternate readouts such as enzyme complementation or fluorescence resonance energy transfer (FRET). 

The objectives of this book will have been met if improved communication on the subject of detection results. Such communication would be beneficial not only between the public and the technical community, but also within the technical community. As indicated in the overview chapter, the history of detection limits in analytical chemistry has been marked by an unfortunate degree of diversity in terminology and meaning and a lack of attention to the probabilities of both false negatives and false positives. At the same time, we should help the public understand that all detection limits must allow for these two types of error, and that zero detection limits cannot, in principle, be attained. 

The use of aerosol disinfectant preparations when collecting specimens may contaminate the sample if an aerosol propellant is used. Contamination of blood samples with ethanol or 2-propanol may also occur if an alcohol-soaked swab is used to cleanse skin prior to venepuncture. Gross contamination with technical xylene (a mixture of o-, m-, and p-xylene together with ethylbenzene) has been found in blood collected into Sarstedt Monovette Serum Gel blood collection tubes contamination with toluene (up to 22 mg 1 ), 1-butanol, ethylbenzene, and xylene has been found in batches of these same tubes. Contamination with 1-butanol or 2-methyl-2-prop-anol occurs commonly in blood collected into tubes coated with EDTA. Care should be taken when handling frozen tissue prior to analysis as any compounds present in ambient air may condense on the cold surface and give rise to false positives. Processing blank frozen tissue can control for this possibility. 

A review of the current state of scientific and technical knowledge on evaluation of the pre-crash phase set the starting point for this thesis (Chap. 2). Safety evaluation can be conducted at different levels (e.g., component-, system-, vehicle-based or with focus on the overall benefits in traffic). The method of choice depends on the level of evaluation and the underlying research question. Functions of active safety rely on sensors which perceive information from their environment and are thus subjeet to uneertainty. Besides possible technical limitations, the prediction of future movements of all involved participants contributes to this inherent uncertainty. As a eonsequenee, systems subject to uncertainties will not work perfectly in the sense of reliability. False-positive activations, e.g., due to misinterpretation of information or technical limitations, will occur with consequences on acceptance and controllability of the system. With an increasing number of false-positive activations, acceptance by the driver will decrease. In case of severe interventions in traffic, such as high velocity reductions and sharp decelerations, false-positive activations become a matter of controllability for the driver and the surrounding traffic and can ultimately have a negative impact on safety. 

CAD techniques for CTC have advanced substantially during the last several years. As a result, a fundamental CAD scheme for the detection of polyps has been established, and commercial products are now available. Thus far, CAD shows the potential for detecting polyps and cancers with high sensitivity and with a clinically acceptable low false-positive rate. However, CAD for CTC needs to be improved further for more accurate and reliable detection of polyps and cancers. There are a number of technical challenges that CAD must overcome, and the resulting CAD systems should be evaluated based on large-scale, multicenter, prospective clinical trials. If the assistance in interpretation offered by CAD is shown to improve the diagnostic performance sub-... 

Technical Artefacts Causing False Positive Findings 101... 

The latest prototype CAD systems yield a clinically acceptable high sensitivity and a low false-positive rate (see Sect. 11.4), and they are becoming integrated into the 3D workstation for CTC examinations and thus into clinical workflow. However, some technical and clinical challenges still remain as open problems for CAD to become a clinical reality. 

---